Skip to main content

Peer Review reports

From: Can the prophylactic quadrivalent HPV vaccine be used as a therapeutic agent in women with CIN? A randomized trial

Original Submission
16 Oct 2019 Submitted Original manuscript
16 Nov 2019 Reviewed Reviewer Report - Sveinung Sørbye
17 Dec 2019 Reviewed Reviewer Report - Abram Wagner
30 Jan 2020 Author responded Author comments - Mojgan Karimi-Zarchi
Resubmission - Version 2
30 Jan 2020 Submitted Manuscript version 2
4 Feb 2020 Reviewed Reviewer Report - Sveinung Sørbye
11 Feb 2020 Author responded Author comments - Mojgan Karimi-Zarchi
Resubmission - Version 3
11 Feb 2020 Submitted Manuscript version 3
16 Feb 2020 Author responded Author comments - Mojgan Karimi-Zarchi
Resubmission - Version 4
16 Feb 2020 Submitted Manuscript version 4
Publishing
18 Feb 2020 Editorially accepted
27 Feb 2020 Article published 10.1186/s12889-020-8371-z

You can find further information about peer review here.

Back to article page